Načítá se...
Problems With Public Reporting of Cancer Quality Outcomes Data
The authors say public reporting of even the most well-defined end points—survival after treatment—can be misleading when used to compare outcomes across providers, and these data can suffer from patient-selection and treatment-intensity biases.
Uloženo v:
| Vydáno v: | J Oncol Pract |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Clinical Oncology
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795653/ https://ncbi.nlm.nih.gov/pubmed/24839285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2014.001405 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|